ALX Oncology Holdings Inc.ALXONASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank29
3Y CAGR-30.5%
5Y CAGR-48.1%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-30.5%/yr
vs +55.9%/yr prior
5Y CAGR
-48.1%/yr
Recent acceleration
Acceleration
-86.4pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
5 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$16.37M-6.8%
2024$17.57M-21.6%
2023$22.41M-54.1%
2022$48.82M-86.6%
2021$363.67M-16.2%
2020$434.22M+4715.6%
2019$9.02M+9.1%
2018$8.26M-